For this situation, we hypothesised that up-regulation of membrane PD-L1 in the patients with sEV PD-1/CD80high-PD-L1low might reflect the insensitivity of tumour cells to I-sEVs, leading to potentially enhanced responses to immunotherapy. Here, PDCD1 is linked to neoplasm.